Ocrevus subkutan 920 mg/23 ml, Injektionslösung
7680689880013
CH-68988
Injektionslösung
Associated product:
OCREVUS sous-cutané sol inj 920 mg/23 ml flac
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ocrelizumabum
|
920.0 MG | Substance | Wirkstoff (Principe actif) |
|
hyaluronidasum humanum ADNr
|
- | Substance | HNIDK |
|
trehalosum dihydricum
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
methioninum
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
8.4 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 9813.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2025
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 68988
- Drug name
- Ocrevus subkutan, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L04AG08
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 15/11/2024
- Authorization expiration date
- 14/11/2029
- IT Number
- 01.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- OCREVUS sous-cutané sol inj 920 mg/23 ml flac
- Description (DE)
- OCREVUS subkutan Inj Lös 920 mg/23 ml Durchstf
- Market launch
- 15/11/2024
- Narcotic (BTM)
- No